Related Experiment Video
Updated: Dec 21, 2025

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
Published on: May 21, 2017
Aortic valve replacement with or without concomitant coronary artery bypass grafting in very elderly patients aged
Kazuyoshi Takagi1, Koichi Arinaga2, Tohru Takaseya2
1Division of Cardiovascular Surgery, Department of Surgery, Kurume University School of Medicine, 67 Asahimachi, Kurume, 830-0011, Japan. takagi13@me.com.
Insights
Aortic valve replacement (AVR) with or without coronary artery bypass grafting (CABG) is safe for patients 85 and older. Outcomes, including survival, were similar between groups, demonstrating acceptable early and long-term results.
Area of Science:
- Cardiology
- Cardiac Surgery
- Geriatric Medicine
Background:
- Degenerative aortic stenosis is a prevalent condition in the aging population.
- While less invasive options exist, open-heart surgery remains crucial for elderly patients with complex cardiac conditions.
- Severe coronary artery disease often necessitates combined procedures during aortic valve replacement.
Purpose of the Study:
- To analyze the outcomes of very elderly patients (≥85 years) undergoing aortic valve replacement (AVR).
- To compare outcomes between isolated AVR and AVR combined with coronary artery bypass grafting (CABG) in this age group.
Main Methods:
- Retrospective analysis of 29 patients aged ≥85 years undergoing AVR.
- Patients were divided into two groups: AVR with CABG (Group AC, n=11) and isolated AVR (Group A, n=18).
- Outcomes assessed included operative mortality, morbidity, length of stay, and long-term survival rates.
Main Results:
- Aortic cross-clamp time was significantly longer in Group AC (126.5 min) compared to Group A (96.9 min).
- Major morbidity rate was higher in Group AC (36%) versus Group A (6%).
- No significant differences were observed in 30-day mortality, hospital mortality, ICU/hospital stay, or long-term survival rates between the groups.
Conclusions:
- Aortic valve replacement with or without CABG can be safely performed in carefully selected very elderly patients.
- The procedure offers acceptable early and long-term results for patients aged 85 and above.
- Combined AVR and CABG demonstrates comparable outcomes to isolated AVR in terms of mortality and survival in this population.
Abstract:
Degenerative aortic stenosis is the most common structural heart valve disease affecting the aging population. Catheter-based heart valve interventions are less invasive and very useful for very elderly patients. However, we often consider open heart surgery for these patients because of anatomical reasons and co-existing cardiac diseases, i.e., severe coronary artery disease. We aimed to analyze the outcomes of very elderly patients aged ≥ 85 years undergoing aortic valve replacement (AVR) with or without coronary artery bypass grafting (CABG). Twenty-nine very elderly patients aged ≥ 85 years who underwent AVR with CABG (n = 11, Group AC) or isolated AVR (n = 18, Group A) were examined. The overall mean age of the patients was 87.2 ± 2.6 (range 85-94) years. The estimated operative mortality rate, calculated using the Japan score, EuroSCORE II, and STS risk score, was 5.72%-10.88% in Group AC and 5.63%-8.30% in Group A. Aortic cross-clamp time (126.5 ± 29.0 vs. 96.9 ± 29.2 min, p = 0.016) was significantly longer in Group AC than in Group A. Although the major morbidity rate was higher in Group AC than in Group A (36% vs. 6%, p = 0.0336), the length of intensive care unit stay and hospital stay was comparable between both groups. There was no 30-day and hospital mortality in both groups. Eleven patients died during follow-up (senility, 5; cerebrovascular events, 2; renal failure, 1; unknown, 3). There were no significant differences in survival rates during follow-up (log-rank p value = 0.1051). The 1-, 2-, 3-, 4- and 5-year survival rates were 91%, 80%, 69%, 69% and 69%, respectively, in Group AC and 94%, 94%, 94%, 94% and 88%, respectively, in Group A. In conclusion, AVR with or without CABG could be safely performed in carefully selected very elderly patients with acceptable early- and long-term results. AVR with CABG in very elderly patients aged ≥ 85 offers similar results to isolated AVR in terms of 30-day mortality, hospital mortality, and long-term survival.
More Related Videos
Related Concept Videos
Aortic Regurgitation III: Medical Management
Mitral Stenosis III: Medical Management
Aortic Regurgitation I: Introduction
Aortic Regurgitation IV: Nursing Management
Mitral Stenosis I: Introduction
Mitral Regurgitation III: Medical Management

